Skip to main content
Log in

Symptomatic atrial fibrillation: management depends on the pattern presented

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kannel WB, Wolf PA, Benjamin EJ, et al. Prevalence, incidence, prognosis and predisposing conditions for atrial fibrillation: population based estimates. Am J Cardio 1998; 82: 2N–9N

    Article  CAS  Google Scholar 

  2. Howard PA, Guidelines for stroke prevention in patients with atrial fibrillation. Drugs 1999; 58(6): 997–1009

    Article  PubMed  CAS  Google Scholar 

  3. Haghi D, Schumacher B. Current management of symptomatic atrial fibrillation. Am J Cardiovasc Drugs 2001; 1(2): 127–39

    Article  PubMed  CAS  Google Scholar 

  4. Fuster V, Rydén, LE, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. Circulation 2001; 104: 2118–50

    PubMed  CAS  Google Scholar 

  5. Channer, KS. Current management of symptomatic atrial fibrillation. Drugs 2001; 61(10): 1425–37

    Article  PubMed  CAS  Google Scholar 

  6. Roy D, Talajic M, Dorian P, et al. Amiodarone to prevent recurrence of atrial fibrillation. N Eng J Med 2000; 342: 913–20

    Article  CAS  Google Scholar 

  7. Levy S, Breithardt G, Campbell RWF, et al. Atrial fibrillation: current knowledge and recommendations for management. Eur Heart J 1998; 19: 1294–320

    Article  PubMed  CAS  Google Scholar 

  8. Guarnieri T, Holan S, Gottlieb SO, et al. Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the ARCH trial. J Am Coll Cardio 1999; 34: 343–7

    Article  CAS  Google Scholar 

  9. Daoud EG, Strickberger SA, Man KC, et al. Preoperative amiodarone as prophylaxis against atrial fibrillation after open heart surgery. N Engl J Med 1997; 337: 1785–91

    Article  PubMed  CAS  Google Scholar 

  10. Channer KS, Greenbaum R, Lebman R, et al. Oral dofetilide for conversion of atrial fibrillation/flutter to sinus rhythm: time to cardioversion and duration of hospital [abstract]. Eur Heart J 1992; 20: 1850

    Google Scholar 

  11. Kassotis J, Costeas C, Blitzer M, et al. Rhythm management in atrial fibrillation: with a primary emphasis on pharmacologic therapy, Part 3. Pacing Clin Electrophysiol 1998; 21(5): 1133–45

    Article  PubMed  CAS  Google Scholar 

  12. Jung F, DiMarco JP. Treatment strategies for atrial fibrillation. Am J Med 1998; 104(3): 272–86

    Article  PubMed  CAS  Google Scholar 

  13. Channer KS. The drug treatment of atrial fibrillation. Br J Clin Pharmacol 1991; 32: 267–73

    Article  PubMed  CAS  Google Scholar 

  14. Farshi R, Kistner D, Sarma JS, et al. Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regiments. J Am Coll Cardiol 1999; 33(2): 304–10

    Article  PubMed  CAS  Google Scholar 

  15. Williamson BD, Chingman K, Daoud E, et al. Radio frequency catheter modification of atrio-ventricular rate during atrial fibrillation. N Engl J Med 1994; 331: 910–7

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Symptomatic atrial fibrillation: management depends on the pattern presented. Drugs Ther. Perspect 18, 10–13 (2002). https://doi.org/10.2165/00042310-200218070-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200218070-00004

Keywords

Navigation